717
Views
32
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Decline in FEV1 in Relation to Incident Chronic Obstructive Pulmonary Disease in a Cohort with Respiratory Symptoms

, , , , &
Pages 5-13 | Published online: 02 Jul 2009

REFERENCES

  • Anto J M, Vermiere P, Vestbo J, Sunyer J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir J May, 2001; 17(5)982–994
  • Gulsvik A. The global burden and impact of chronic obstructive pulmonary disease worldwide. Monaldi Arch Chest Dis 2001; 56(3)261–264
  • Lange P, Groth S, Nyboe J, Mortensen J, Appleyard M, Jensen G, Schnohr P. Effects of smoking and changes in smoking habits on the decline of FEV1. Eur Respir J 1989; 2(9)811–816
  • Bakke P S, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to occupational title and exposure to some airborne agents. Thorax 1991; 46: 863–870
  • Sobradillo V, Miravitlles M, Jimenez C A, Gabriel R, Viejo J L, Masa J F, Fernandez-Fau L, Villsante C. Epidemiological study of chronic obstructive pulmonary disease in Spain (IBERPOC): prevalence of chronic respiratory symptoms and airflow limitation. Arch Bronchoneumol 1999; 35(4)159–166
  • Mannino D M, Gahnon R C, Petty T L, Lydick E. Obstructive lung disease and low lung function in adults in the United States. Data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2000; 160: 1683–1989
  • Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson A C, Jönsson E, Larsson L G, Andersson S, Sandström T, Lundbäck B. Not 15 but 50% of smokers develop COPD?—Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir Med 2003; 97(2)115–122
  • Huhti E, Ikkala J. A follow-up study on respiratory symptoms and ventilatory function in a middle-aged rural population. Eur J Respir Dis 1980; 61: 33–45
  • Krzyzanowski M, Jedrychowski W, Wysocki M. Factors associated with the change in ventilatory function and the development of chronic obstructive pulmonary disease in a 13-year follow up of the Cracow study. Am Rev Respir Dis 1986; 134: 1011–1019
  • Heederik D, Kromhout H, Burema J, Biersteker K, Kromhout D. Occupational exposure and 25 years incidence rate of non-specific lung disease—the Zutphen study. Int J Epidemiol 1990; 19: 945–952
  • Vestbo J, Lange P. Can GOLD stage 0 provide information of prognostic value in Chronic Obstructive Lung Disease?. Am J Respir Crit Care Med 2002; 166: 329–332
  • Lindberg A, Jonsson A C, Ronmark E, Lundgren R, Larsson L G, Lundbäck B. Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort. Chest May, 2005; 127(5)1544–1552
  • Fletcher T, Peto R, Tinker C, et al. The Natural History of Chronic Bronchitis and Emphysema. Oxford University Press, Oxford 1976
  • Sherman C B, Xu X, Speizer F E, Ferris B G, Jr., Weiss S T, Dockery D W. Longitudinal lung function decline in subjects with respiratory symptoms. Am Rev Respir Dis 1992; 146: 855–859
  • Xu X, Weiss S T, Rijcken B, Schouten J P. Smoking, changes in smoking habits, and rate of decline in FEV1: new insights into gender differences. Eur Respir J Jun, 1994; 7(6)1056–1061
  • Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease. Copenhagen City Heart Study. Am J Crit Care Med May, 1996; 153(5)1530–1535
  • Camilli A, Burrows B, Knudson R, Lyle S K, Lebowitz M D. Longitudinal changes in forced expiratory volume in one second in adults. Am Rev Respir Dis 1987; 135: 794–799
  • Anthonisen N R, Connett J E, Murray R P. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med Sep 1, 2002; 166(5)675–679
  • Rijcken B, Britton J. Epidemiology of chronic obstructive pulmonary disease. Eur Respir Mon May, 1998; 7(3)s41–s73
  • Lundbäck B, Nystrom L, Rosenhall L, Stjernberg N. Obstructive lung disease in northern Sweden: respiratory symptoms assessed in a postal survey. Eur Respir J 1991; 4(3)257–266
  • Lundbäck B, Stjernberg N, Nyström L, Forsberg B, Lindström M, Lundbäck K, Jönsson E, Rosenhall L. Epidemiology of respiratory symptoms, lung function and important determinants. Report from the Obstructive Lung Disease in Northern Sweden Project. Tuber Lung Dis 1994; 75(2)116–126
  • Celli B R, MacNee W, and committee members. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23: 932–946
  • Medical Research Council's Committee. On aetiology of chronic bronchitis—Standardized questionnaires on respiratory symptoms. Br Med J 1960; ii: 1665
  • Lindström M, Kotaniemi J, Jönsson E, Lundbäck B. Smoking, respiratory symptoms, and diseases: a comparative study between northern Sweden and northern Finland—a report from the FinEsS study. Chest 2001; 119: 852–886
  • Pallasaho P, Lundbäck B, Meren M, Kiviloog J, Loit H M, Larsson K, Laitinen L A. Prevalence and risk factors for asthma and chronic bronchitis in the capitals Helsinki, Stockholm, and Tallinn. Respir Med 2002; 96(10)759–769
  • ATS statement. Snowbird workshop on standardization of spirometry. Am Respir Dis 1979; 119: 831–838
  • Berglund E, Birath G, Bjure J, Grimby G, Kjellmer I, Sandqvist L, Söderholm B. Spirometric studies in normal subjects, Forced expirograms in subjects between 7 and 70 years of age. Acta Med Scand 1963; 173: 185–192
  • Statistics Sweden. The Socio-economic Classification of Occupations. Stockholm, Sweden 1982
  • Willemse B WM, Postma D S, Timens W, ten Hacken N HT. The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation. Eur Respir J 2004; 23: 464–476
  • Sherrill D L, Enright P, Cline M, Burrows B, Lebowitz M D. Rates of decline in lung function among subjects who restart cigarette smoking. Chest 1996; 109: 1001–1005
  • Viegi G, Pedreschi M, Pistelli F, Di Pede F, Baldacci S, Carrozzi L, Giuntini C. Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition. Chest 2000; 117: 339S–345S, (5 Suppl 2)
  • Soriano J B, Maier W C, Egger P, Visick G, Thakrar B, Sykes J, Pride N B. Recent trends in physician diagnosed COPD in women and men in the UK. Thorax 2000; 55: 789–794
  • Prescott E, Bjerg A M, Andersen P K, Lange P, Vestbo J. Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. Eur Respir J 1997; 10(4)822–827
  • Langhammer A, Johnsen R, Gulsvik A, Holmen T L, Bjermer L. Sex differences in lung vulnerability to tobacco smoking. Eur Respir J 2003; 21(6)1017–1023
  • British Thoracic Society. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52: 1S–28S, (Suppl 5)
  • www.goldcopd.com
  • Hardie J A, Buist A S, Vollmer W M, Ellingsen I, Bakke P S, Morkve O. Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers. Eur Respir J 2002; 20(5)1117–1122
  • Celli B R, Halbert R J, Isonaka S, Schau B. Population impact of different definitions of airway obstruction. Eur Respir J 2003; 22: 268–273
  • Lundbäck B, Stjernberg N, Nyström L, Lundbäck K, Lindström M, Rosenhall L. An interview study to estimate prevalence of asthma and chronic bronchitis. Eur J Epidemiol Mar, 1993; 9(2)123–133

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.